SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
Nikolaos C. Kyriakidis, Andrés López‐Cortés, Jorge Vásconez-González, Alejandra Barreto-Grimaldos, Esteban Ortiz‐Prado · 2021
Read SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates by Nikolaos C. Kyriakidis, Andrés López‐Cortés, Jorge Vásconez-González, Alejandra Barreto-Grimaldos, Esteban Ortiz‐Prado (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w3133277826.txt.
Description
Nikolaos Kyriakidis, Andrés López-Cortés, Jorge Vásconez-González, and colleagues wrote this review in npj Vaccines in 2021. It surveys vaccine strategies against SARS-CoV-2, the virus behind COVID-19, focusing on candidates that had reached final phase three trials. By early January 2021 the pandemic had killed more than one point eight million people.
Most leading candidates aim to raise antibodies that block the viral spike protein and stop it latching onto human cells. Growing evidence on the role of T cells pushed some designs to favor cellular immunity as well. Others use whole killed or weakened virus to draw a broader response. The review compares these platforms, their trial designs, and their early results for readers judging a crowded field.
Catalog record
| CREATOR | Nikolaos C. Kyriakidis, Andrés López‐Cortés, Jorge Vásconez-González, Alejandra Barreto-Grimaldos, Esteban Ortiz‐Prado |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 117 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | OpenAlex / npj Vaccines |